re: Ann: Complete Response Letter from FDA Re... Good percentage of buyers seem to have been daytraders. Rally was over in less than 10 minutes!!!
Interesting to see if this causes RBS to revise its price target. RBS downgraded its price target from $1.51 a share to 45c after the initial news on 23/3/2010. In the absence of other factors or analyst reports, this single downgrade appears to explain why the share price had not moved much further north of 45c. Interesting to see if the news today forces RBS to revisit its rather arbitrary downgrade.
- Forums
- ASX - By Stock
- CXS
- Ann: Complete Response Letter from FDA Received
Ann: Complete Response Letter from FDA Received , page-13
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online